The Carrier Quietly Setting Up Its Next Run
One national network just lined up fresh financing, scored a credit upgrade, and teed up a leadership handoff.
This is a steady setup into year end that could get more interesting as rates drift and cash returns stay in focus.

Your Partner in Delegation
You’ve done it all. Built your business, clawed your way into the green, pulled every lever you could pull. And you did it all by digging in.
But now? Your work days creep later and later. Big plans get pushed one more day. The urgent task always wins over the important one.
You’ve reached capacity. It’s not about working harder now. It’s about growing smarter.
BELAY’s Delegate to Elevate eBook shows how to break through the ceiling by letting go of the tasks holding you back. You’ll discover the mindset shift and strategies successful entrepreneurs use to free up time and focus on scaling.
It’s the tipping point: delegate to elevate — or stay stuck.

Want to make sure you never miss a stock recommendation?
Elite Trade Club now offers text alerts — so you get trending stocks and market-moving news sent straight to your phone before the bell. Email’s great. Texts are faster.


Datadog
Ticker: DDOG | Market Cap: $57.2B | Catalyst: Large renewal watch and AI observability momentum
UBS lifted its target to 189 on improving odds that OpenAI, highlighted as Datadog’s largest customer, renews. Street checks suggest ClickHouse is nibbling at log workloads, but not enough to blow up the relationship. Meanwhile, the platform crossed 1,000 integrations, added GPU monitoring, and deepened ties with leading model providers.
Other brokers pushed targets to 170 to 190 on usage trends and AI-native customer growth. The stock already had a strong run, trades rich on earnings, and sits near its 52-week high, so expect swings around any renewal color.
What you should watch: Concrete renewal disclosures, consumption growth in logs and infrastructure, and attach on security modules. If usage reaccelerates into Q4 while gross retention stays high, the bull case for durable 25 to 30 percent top line holds together.

Smart Money Moves (Sponsored)
Your portfolio might be doing fine.
But why stop at fine when you could aim for game-changing gains?
Our analysts have just released a new special report, highlighting 5 stocks with the potential to double.
These aren’t random picks.
They were hand-selected because they combine:
Proven fundamentals with long-term staying power
Technical strength suggesting momentum is building now
Past reports have pinpointed stocks before huge runs of +175%, +498%, even +673%.¹
This exclusive report is yours free—but only until midnight tonight.
[Click here now to download your copy instantly]
Why settle for average when extraordinary is on the table?
*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.


Intuitive Surgical
Ticker: ISRG | Total Assets: $159.1B | Catalyst: FDA-cleared AI upgrade for Ion lung platform
The Ion Endoluminal System picked up FDA clearance for software that layers AI into navigation. Think real time course correction for CT-to-body divergence plus integrated tomosynthesis that delivers 3D-like imaging via a standard C-arm. This can expand reach to hard nodules, push diagnostic yield higher, and support recurring instrument revenue per system.
Rollout starts limited, then broadens in 2026, which lines up with the usual lap between clearance and full commercial impact. Shares are down year to date, so credible evidence of better targeting and faster workflows can be a sentiment reset.
What you should watch: Early hospital feedback from the limited launch, attach rates and per-procedure economics, and whether Ion placements accelerate in 2026 budgets. If the company pairs Ion traction with steady da Vinci volumes, the multiple has room to breathe.


Ulta Beauty
Ticker: ULTA | Market Cap: $25.2B | Catalyst: Margin beat meet holiday playbook
Q2 gross margin ticked up to 39.2 percent, a 90 bps lift helped by lower shrink and smarter promos. SG&A ran hot, but the merchandising engine and loyalty flywheel remain the moat heading into gifting season.
Management flagged occupancy and supply chain costs that could pinch, yet shrink improvement is broad based and should persist. With the stock near highs, holiday execution will do the talking.
What you should watch: Loyalty growth and basket size, promo cadence in November, and category mix in prestige versus mass. If traffic holds and shrink gains stick, full year margin glide paths can top cautious models and keep the multiple supported.

Win All Markets (Sponsored)
Volatility is creating some of the biggest trading opportunities in years — but only for those who know how to use it.
That’s why we’re giving investors one last chance to claim their free copy of Mastering Options Trading: A Beginner’s Guide before it’s gone.
If you’ve ever wanted to learn how to trade smarter — this is your moment.
But hurry — this free access expires at midnight.
Download your free copy now before the opportunity disappears.


Constellation Energy
Ticker: CEG | Market Cap: $119.7B | Catalyst: Data center load meets nuclear scale
The AI buildout is moving from retrofit to greenfield and that needs firm power. CEG operates the largest nuclear fleet in the US, with roughly 32 GW of capacity and about 90 percent carbon-free output. That profile makes it a go-to counterparty for hyperscalers signing long-dated power contracts. The stock has surged year to date, so expectations are no longer shy, but policy tailwinds plus contract visibility can extend the move.
What you should watch: Any new long term power agreements tied to data centers, clarity on pricing uplift and duration, and capital allocation between growth projects and dividends. If contract disclosure shows step ups in realized prices, cash flow forecasts likely march higher.


T-Mobile US
Ticker: TMUS | Market Cap: $254.6B | Catalyst: Debt raise, credit upgrade, and CEO transition
The pink giant is printing new paper. A subsidiary plans to raise about $2.8 billion across 2033, 2035, and 2056 senior notes at coupons of 4.625, 4.950, and 5.700 percent. Proceeds go to refinance existing debt and general corporate uses, which helps keep interest expense in check while preserving capital flexibility. Moody’s bumped backed senior unsecured notes to Baa1 with a stable outlook, a nice tailwind for future funding costs.
Leadership is rotating as Srini Gopalan takes the top job on November 1 with Mike Sievert moving to Vice Chair to focus on strategy. Analysts remain constructive with Buy ratings and targets in the mid to high 200s. Shares are off the highs, yield sits near 1.8 percent, and valuation around 21 times earnings looks reasonable for a scale player with low churn and fixed wireless momentum.
What you should watch: Pricing discipline as competitors chase promos, any update on buyback cadence tied to free cash flow, and whether the new CEO frames a multiyear capex and cash return plan before holiday quarter commentary. If credit spreads stay friendly and execution holds, the setup favors multiple stability with upside on capital return signals.

Poll: Which 2020s trend will be most studied by economists in 2050?

This week blends a carrier tightening the bolts on its balance sheet, a software platform navigating a high-stakes renewal, a surgical innovator pushing AI deeper into lung care, a retailer fine tuning margin ahead of peak season, and a baseload generator riding an AI power wave.
Different industries, same playbook. Follow the catalysts, let the numbers confirm the thesis, and keep a little dry powder for those inevitable dips that great stories give you on the way up.
That’s all for today. Thank you for reading. If you have any feedback, please reply to this email.
Best Regards,
— Adam Garcia
Elite Trade Club
Click here to get our daily newsletter straight to your cell for free.
P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.
Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website, which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside these emails.